Treatment of reactive arthritis: A practical guide

BioDrugs

Volumn 13, Issue 1, 2000, Pages 21-28

  Rudwaleit, Martin ^a   Braun, Jürgen ^a   Sieper, Joachim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

CAMPYLOBACTER; CHLAMYDIA; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW; RISK BENEFIT ANALYSIS; SALMONELLA; SHIGELLA; YERSINIA;

EID: 0033964535     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200013010-00003     Document Type: Review

References (42)

1. 1. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983; 309: 1606-15
2. 2. Aho K, Leirisalo-Repo M, Repo H. Reactive arthritis. Clin Rheum Dis 1985; 11: 25-40
3. 3. Kingsley G, Sieper J. Third international workshop on reactive arthritis. Ann Rheum Dis 1996; 55: 564-70
4. 4. Glennas A, Kvien TK, Melby K, et al. Reactive arthritis: a favorable 2 year course and outcome, independent of triggering agent and HLA-B27. J Rheumatol 1994; 21: 2274-80
5. 5. Leirisalo-Repo M. Prognosis, course of disease, and treatment of spondylarthropathies. Rheum Dis Clin North Am 1998; 24: 737-51
6. 6. Leirisalo-Repo M. Suoranta H. Ten-year follow up of patients with Yersinia arthritis. Arthritis Rheum 1988; 31: 533-7
7. 7. Amor B. Reiter's syndrome: long-term follow-up data. Ann Rheum Dis 1979; 38 Suppl.: 32-3
8. 8. Leirisalo-Repo M, Helenius P, Hannu T, et al. Long-term prognosis of reactive Salmonella arthritis. Ann Rheum Dis 1997; 56: 516-20
9. 9. Sieper J, Braun J. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum 1995; 38: 1547-54
10. 10. Yin Z, Braun J, Neurc L, et al. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum 1997; 40: 1788-97
11. 11. Braun J, Yin Z, Spiller I, et al. A low TNFα-secretion of peripheral blood mononuclear cells but no other T helper 1 or 2 cytokines correlates with chronicity in reactive arthritis. Arthritis Rheum 1999; 42: 2039-44
12. 12. Toivanen A. Reactive arthritis. In: Klippel JH, Dieppe PA, editors. Practical rheumatology. St Louis (MO): Mosby, 1995: 287-94
13. 13. Kingsley G. Microbial DNA in the synovium - a role in actiology or a mere bystander? Lancet 1997; 349: 1038-9
14. 14. Nanagara R, Li F, Beutler A, et al. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum 1995; 38: 1410-7
15. 15. Nikkari S, Merilahti Palo R, Saario R, et al. Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens. Arthritis Rheum 1992; 35: 682-7
16. 16. Nikkari S, Möttönen T, Saario R, et al. Demonstration of Salmonella DNA in the synovial fluid in reactive arthritis. Arthritis Rheum 1996; 39: S185
17. 17. Braun J, Tuszewski M, Eggens U, et al. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. J Rheumatol 1997; 24: 1092-100
18. 18. Wilkinson NZ, Kingsley GH, Jones HW, et al. The detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritides using a nested, broad-range polymerase chain reaction. Rheumatology 1999; 38: 260-6
19. 19. Popert AJ, Gill AJ, Laird SM. A prospective study of Reiter's syndrome. An interim report on the first 82 cases. Br J Venereol Dis 1964: 40: 160-5
20. 20. Fryden A, Bengtsson A, Foberg U. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. BMJ 1990; 301: 1299-302
21. 21. Locht H, Kihlstrom E, Lindstrom FD. Reactive arthritis after Salmonella among medical doctors - study of an outbreak. J Rheumatol 1993; 20: 845-8
22. 22. Mattila L, Leirisalo-Repo M, Pelkonen P, et al. Reactive arthritis following an outbreak of Salmonella bovismorbificans infection. J Infect 1998; 36: 289-95
23. 23. Zhang Y, Gripenberg Lerche C, Soderstrom KO, et al. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model. Arthritis Rheum 1996; 39: 1238-43
24. 24. Lauhio A, Leirisalo Repo M, Lahdevirta J, et al. Double-blind, placebo-controlled study of three-month treatment with lymecyclinc in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991; 34: 6-14
25. 25. Toivanen A, Yli Kerttula T, Luukkainen R, et al. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993; 11: 301-7
26. 26. Sieper J, Fendler C, Laitko S, et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis (ReA): possible differences in Chlamydia-induced and enteric ReA. Arthritis Rheum 1999; 42: 1386-96
27. 27. Kerttula Y, Luukainen R, Yli-Kerttula U, et al. Effect of a three month course of ciprofloxacin on reactive arthritis. Ann Rheum Dis 1999; 58 Suppl.: P122
28. 28. Keat A, Thomas BJ, Taylor Robinson D. Chlamydial infection in the aetiology of arthritis. Br Med Bull 1983; 39: 168-74
29. 29. Bardin T, Enel C, Cornelis F, et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992; 35: 190-4
30. 30. Caul EO, Horner PJ, Leece J, et al. Population-based screening programmes for Chlamydia trachomatis. Lancet 1997; 349: 1070-1
31. 31. Wollenhaupt J, Hammer M, Pott HG, et al. A double-blind placebo-controlled comparison of 2 weeks versus 4 months treatment with doxycycline in Chlamydia-induced arthritis. Arthritis Rheum 1997; 40: S143
32. 32. Beutler AM, Hudson AP, Whittum-Hudson JA. Chlamydia trachomatis can persist in joint tissue after antibiotic treatment in chronic Reiter's syndrome/reactive arthritis. J Clin Rheumatol 1997; 3: 125-30
33. 33. Sieper J, Braun J, Kingsley GH. Report on the 4th International Workshop on Reactive Arthritis (Berlin, July 1999). Arthritis Rheum 2000. In press
34. 34. Creemers MCW, van Riel PLCM, Franssen MJAM, et al. Second-line treatment in seronegative spondylarthropathies. Semin Arthritis Rheum 1994; 24: 71-81
35. 35. Berenbaum F, Duvivier C, Kaplan PG. Successful treatment of Reiter's syndrome in a patient with AIDS with methotrexate and corticosteroids. Br J Rheum 1996; 35: 295
36. 36. Mielants H, Veys EM, Joos R. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis. Clin Rheumatol 1986; 5: 80-3
37. 37. Dougados M, Van der Linden S, Leirisalo-Repo M, et al. Sulfasalazine in the treatment of spondylarthropathy. Arthritis Rheum 1995; 38: 618-27
38. 38. Clegg DO, Reda DJ, Weisman MH, et al. Comparison of sulfasalazin and placebo in the treatment of reactive arthritis (Reiter's syndrome). Arthritis Rheum 1996; 39: 2021-7
39. 39. Egsmose C, Mork Hansen T, Smedegaard Andersen L, et al. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial. Ann Rheum Dis 1997; 56: 32-6
40. 40. Clegg DO, Reda DJ, Weisman MH, et al. Comparison of sulfasalazin and placebo in the treatment of ankylosing spondylitis. Arthritis Rheum 1996; 39: 2004-12
41. 41. Kirwan J, Edwards A, Huitfeldt B, et al. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years. Br J Rheum 1993; 32: 729-33
42. 42. Leino R, Makela AL, Tiilikainen A, et al. Yersinia arthritis in children. Scand J Rheumatol 1980; 9 (4): 245-9